COMP <GO>
XRAY vs KMTS // EV/EBITDA & P/E VALUATION
DENTSPLY SIRONA Inc. (NASDAQ) VS. Kestra Medical Technologies Ltd. (NASDAQ) • 15-METRIC TALLY: XRAY 7
— KMTS 4
■ METRIC PARITY
LAST: $9.61 (+1.80%) • MKT CAP: $1.92B
valuation
—
LAST: $30.61 (+2.48%) • MKT CAP: $1.82B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XRAY VS. KMTS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XRAY | KMTS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 50.00% | 51.40% | -1.40 | KMTS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.00% | -35.00% | +24.00 | XRAY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 12.27% | -6.40% | +18.67 | XRAY | /fcf-yield <GO> |
| Operating Margin | -11.50% | -60.00% | +48.50 | XRAY | /operating-margins <GO> |
| Net Profit Margin | -16.20% | -60.00% | +43.80 | XRAY | /net-margins <GO> |
| Revenue Growth (YoY) | -3.00% | 59.00% | -62.00 | KMTS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 6.68% | 0.00% | +6.68 | XRAY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 9.65 | -9.20 | KMTS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 5/9 | +1.00 | XRAY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.1 | 57.5 | -2.47 | KMTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.92B | $1.82B | $92.6M | XRAY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XRAY REV | KMTS REV | XRAY GROSS % | KMTS GROSS % | XRAY FCF | KMTS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.68B | $95.1M | 50.0% | 51.4% | $235.0M | -$116.6M |
| FY 2024 | $3.79B | $59.8M | 51.6% | 40.5% | $461.0M | -$100.5M |
| FY 2023 | $3.96B | $27.8M | — | — | $377.0M | -$72.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XRAY // BETA —
KMTS // BETA —